First human test of new oral e. coli vaccine
NCT ID NCT01147445
Summary
This early-stage study tested a new oral vaccine designed to prevent diarrhea caused by harmful E. coli bacteria, a common problem for travelers and children in developing countries. Researchers gave 36 healthy adults different doses of the experimental vaccine to check if it was safe and to see if it triggered an immune response. The main goal was to find the highest dose that could be given without causing severe side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTERITIS ESCHERICHIA COLI are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center - Gastroenterology, Hepatology and Nutrition
Cincinnati, Ohio, 45229-3026, United States
-
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Baltimore, Maryland, 21201-1509, United States
Conditions
Explore the condition pages connected to this study.